Neurology Services Market Report 2026

The neurology services market size has grown strongly in recent years. It will grow from $2.77 billion in 2025 to $2.98 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to the rising prevalence of stroke and epilepsy, growth in the aging population, advancements in neuroimaging technologies, increased healthcare spending, and expansion of specialized neurology clinics.

The neurology services market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for tele-neurology services, the growing burden of chronic neurological disorders, rising investments in neuroscience research, the adoption of artificial intelligence in neurological diagnostics, and the expansion of outpatient neurology services. Major trends in the forecast period include greater use of remote neurological monitoring, integration of artificial intelligence-driven decision support tools, growing preference for minimally invasive neurosurgical procedures, increasing focus on personalized neurology care, and expansion of multidisciplinary neurorehabilitation programs.

The increasing prevalence of neurological disorders is expected to drive the growth of the neurology services market in the coming years. Neurological disorders are conditions that affect the brain, spinal cord, nerves, or muscles, including stroke, Alzheimer’s disease, epilepsy, migraine, and other nervous system diseases, and they represent a leading cause of disability and disease burden globally. This rise is attributed to aging populations and higher survival rates from chronic conditions, resulting in more individuals requiring long-term neurological care. Neurology services support public health by offering specialized diagnostics, advanced imaging, therapeutic interventions, and continuous monitoring for patients with neurological conditions. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based health organization, reported that over 3 billion people worldwide were living with neurological conditions, affecting more than 40 % of the global population, highlighting a substantial disease burden and the urgent need for expanded specialized neurological care services internationally. Consequently, the growing prevalence of neurological disorders is fueling the expansion of the neurology services market.

Leading companies in the neurology services market are focusing on developing standardized planning and implementation resources, such as comprehensive neurology toolkits, to strengthen neurology care systems, enhance service coordination, and align national healthcare delivery with global neurological health goals. Standardized neurology implementation toolkits are structured guidance frameworks that help policymakers and healthcare planners design, prioritize, and integrate neurological services across health systems, ensuring consistent diagnosis, treatment, and long-term care for neurological disorders. For example, in July 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental health organization, launched a neurological disorders implementation toolkit to assist countries in improving diagnosis, treatment, and care delivery under the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders. The toolkit offers practical guidance on governance, service integration, workforce planning, and monitoring, enabling countries to systematically enhance national neurology services and strengthen health system responses to neurological conditions.

In March 2025, InnoSer NV, a Belgium-based preclinical contract research organization (CRO), acquired the CRO business of remynd for an undisclosed sum. This acquisition allows InnoSer to enhance its neurology research capabilities by incorporating specialized neurodegenerative disease mouse models and expanding its preclinical service offerings for Alzheimer’s and Parkinson’s disease research. remynd’s CRO business is a Belgium-based provider of translational neurology research services, delivering advanced in vivo models and expertise to support comprehensive preclinical development of neurodegenerative therapies.

Major companies operating in the neurology services market are HCA Healthcare Inc., Ascension Health plc, Mass General Brigham Inc., University of Pittsburgh Medical Center, Banner Health, Mayo Clinic, Ramsay Health Care Limited, NYU Langone Health, Cleveland Clinic Foundation, Mount Sinai Health System, Johns Hopkins University School of Medicine, UCLA Health, Cedars-Sinai Medical Center, Teladoc Health Inc., Stanford Health Care, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Narayana Health Limited, Aster DM Healthcare Limited, American Well Corporation, Manipal Health Enterprises, The Walton Centre NHS Foundation, Barrow Neurological Institute, NeuroSpine Group.

North America was the largest region in the neurology services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the neurology services market by increasing costs of imported diagnostic equipment, neuroimaging devices, monitoring systems, and specialized medical software. healthcare providers in north america and europe are most affected due to reliance on imported advanced medical technologies, while asia-pacific faces cost pressures in service infrastructure development. these tariffs are increasing operational costs and slowing technology upgrades. however, they are also promoting local manufacturing of medical devices, regional technology partnerships, and increased adoption of cost-efficient digital neurology solutions.

Neurology services encompass a broad range of medical care solutions focused on the diagnosis, treatment, and management of disorders affecting the brain, spinal cord, nerves, and muscles. These services integrate clinical evaluations, advanced diagnostic tools, therapeutic interventions, and long-term care strategies to enhance patient outcomes and quality of life. They are vital for managing complex neurological conditions and are increasingly supported by technology-enabled care models to improve efficiency and care coordination.

The primary service categories in neurology services include diagnostic, monitoring, therapeutic, and surgical services. Diagnostic services evaluate nervous system conditions affecting the brain, spinal cord, and peripheral nerves. Indications include ADHD, mental disorders, stroke, concussion, dementia, multiple sclerosis, psychotic disorders, and others. Payment models include fee-for-service, value-based care, bundled payments, and capitation. End users include hospitals, neurology centers, rehab centers, home-care, and telemedicine platforms.

The neurology services market includes revenues earned by entities through services such as neurological examinations, neuroimaging (for example, magnetic resonance imaging and computed tomography scans), electrodiagnostic testing (for example, electroencephalography and electromyography), neurosurgical procedures, rehabilitation services, tele-neurology consultations, and chronic condition management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.